These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37269322)

  • 1. Stent failure: the diagnosis and management of intracoronary stent restenosis.
    Protty MB; Dissanayake T; Jeffery D; Hailan A; Choudhury A
    Expert Rev Cardiovasc Ther; 2023; 21(7):501-506. PubMed ID: 37269322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
    Giustino G; Colombo A; Camaj A; Yasumura K; Mehran R; Stone GW; Kini A; Sharma SK
    J Am Coll Cardiol; 2022 Jul; 80(4):348-372. PubMed ID: 35863852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge.
    Donisan T; Madanat L; Balanescu DV; Mertens A; Dixon S
    Curr Cardiol Rev; 2023; 19(3):e030123212355. PubMed ID: 36597603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Stent Restenosis.
    Kawai K; Virmani R; Finn AV
    Interv Cardiol Clin; 2022 Oct; 11(4):429-443. PubMed ID: 36243488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; Otaegui I; Masotti M; Zueco J; Veláquez M; Sanchís J; García-Touchard A; Lázaro-García R; Moreu J; Bethencourt A; Cuesta J; Rivero F; Cárdenas A; Gonzalo N; Jiménez-Quevedo P; Fernández C;
    JACC Cardiovasc Interv; 2016 Jun; 9(12):1246-1255. PubMed ID: 27339840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum apoA-I with in-stent restenosis in coronary heart disease.
    Wang X; Zhang M; Cheng J; Zhou H
    BMC Cardiovasc Disord; 2022 Aug; 22(1):355. PubMed ID: 35927634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
    Greco A; Sciahbasi A; Abizaid A; Mehran R; Rigattieri S; de la Torre Hernandez JM; Alfonso F; Cortese B
    Catheter Cardiovasc Interv; 2022 Oct; 100(4):544-552. PubMed ID: 36054266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of coronary artery in-stent restenosis.
    Kokkinidis DG; Waldo SW; Armstrong EJ
    Expert Rev Cardiovasc Ther; 2017 Mar; 15(3):191-202. PubMed ID: 28116914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary in-stent restenosis: predisposing clinical and stent-related factors, diagnostic performance and analyses of inaccuracies in 320-row computed tomography angiography.
    Wan YL; Tsay PK; Chen CC; Juan YH; Huang YC; Chan WH; Wen MS; Hsieh IC
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():105-15. PubMed ID: 27106698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waksman In-Stent Restenosis Classification: A Mechanism-Based Approach to the Treatment of Restenosis.
    Shlofmitz E; Case BC; Chen Y; Chezar-Azerrad C; Hashim H; Garcia-Garcia HM; Mintz GS; Waksman R
    Cardiovasc Revasc Med; 2021 Dec; 33():62-67. PubMed ID: 34247983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-stent Restenosis.
    Lee MS; Banka G
    Interv Cardiol Clin; 2016 Apr; 5(2):211-220. PubMed ID: 28582205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Wiebe J; Rai H; Kuna C; Cassese S; Kessler T; Rheude T; Colleran R; Schunkert H; Koch T; Kufner S; Joner M; Kastrati A; Byrne RA
    Catheter Cardiovasc Interv; 2021 Nov; 98(5):857-862. PubMed ID: 32845090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes at 1 Year of Non-Left Main Trunk Bifurcation Lesions Treated With a 2-Stent Strategy Using Newer-Generation Everolimus-Eluting Stents.
    Okabe K; Ohya M; Ikuta A; Takamatsu M; Osakada K; Shimada T; Miura K; Kubo S; Tada T; Tanaka H; Fuku Y; Katoh H; Kadota K
    Circ J; 2021 Oct; 85(11):1972-1980. PubMed ID: 34349075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.
    Wang Z; Yang J; Li C; Huang J; Fezzi S; Chen E; Cai W; Stankovic G; Wijns W; Chen L; Tu S
    Int J Cardiol; 2023 May; 378():11-19. PubMed ID: 36796487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents: current clinical approaches and challenges.
    Sakamoto A; Sato Y; Kawakami R; Cornelissen A; Mori M; Kawai K; Fernandez R; Fuller D; Gadhoke N; Guo L; Romero ME; Kolodgie FD; Virmani R; Finn AV
    Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):801-816. PubMed ID: 33470872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.